VRE spread with oral vancomycin

By  |  December 10, 2008 | 

Patients with moderate to severe Cdiff are commonly treated with oral vancomycin, but there has been a theoretical concern of rectal VRE transmission from these patients. In this prospective observational study of patients with Cdiff and concurrent VRE colonization, researchers cultured skin and environmental samples from patients before, during, and after treatment with vancomycin or metronidazole. They found no difference in VRE-positive skin or environmental cultures between the 2 treatment groups, indicating VRE contamination from oral-vancomycin-treated patients should not be a substantial concern (abstract).

Leave A Comment

About the Author:

Danielle Scheurer
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.


Related Posts

By  | June 29, 2013 |  0
This large systematic review found rectal NSAIDs significantly reduced the risk of post-ERCP pancreatitis compared to pancreatic duct stents (abstract).
By  | June 22, 2013 |  0
This large population-based cohort found the most common causes of drug induced liver injury to be augmentin and diclofenac, followed by herbal and nutritional supplements (abstract).
By  | May 25, 2013 |  0
This large trial of patients with a relative contraindication for enteral feeds were randomized to early TPN or usual care. There were no differences in the groups in 60 day mortality or LOS, but those on TPN did have a shorter time ventilated and less muscle/fat loss. It is unclear based on this trial if […]